Turnstone Biologics Corp. Common Stock Cash Flow Quality Index
Turnstone Biologics Corp. Common Stock cash flow quality index. Turnstone Biologics Corp. Common Stock (TSBX) has a Cash Flow Quality Index of -252.50x as of March 2023. Operating cash flow of $-17.17 Million is below net income of $68.00K, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Turnstone Biologics Corp. Common Stock to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Turnstone Biologics Corp. Common Stock (2021–2021)
Cash flow quality index of Turnstone Biologics Corp. Common Stock from 2021 to 2021. Historical Cash Flow Quality Index for Turnstone Biologics Corp. Common Stock across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore TSBX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Turnstone Biologics Corp. Common Stock Cash Flow Quality Index by Year (2021–2021)
Turnstone Biologics Corp. Common Stock cash flow quality index by year from 2021 to 2021. Year-by-year earnings quality comparison for Turnstone Biologics Corp. Common Stock. For the full cash flow conversion analysis, see TSBX cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -1.37x | $-45.63 Million | $33.27 Million | — |